NCT05174026View on ClinicalTrials.gov

18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Metastatic Malignant NeoplasmMetastatic Malignant Neoplasm in the Bone
Interventions
OTHER

Fludeoxyglucose F-18

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo 18F-FDG PET-MRI

PROCEDURE

Positron Emission Tomography

Undergo 18F-FDG PET-MRI

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT05174026 - 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery | Biotech Hunter | Biotech Hunter